BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23129579)

  • 1. Preventing cervical cancer globally.
    Schmeler KM
    Cancer Prev Res (Phila); 2012 Nov; 5(11):1257-9. PubMed ID: 23129579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer.
    Pierce MC; Guan Y; Quinn MK; Zhang X; Zhang WH; Qiao YL; Castle P; Richards-Kortum R
    Cancer Prev Res (Phila); 2012 Nov; 5(11):1273-9. PubMed ID: 22926339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution microendoscope for the detection of cervical neoplasia.
    Grant BD; Schwarz RA; Quang T; Schmeler KM; Richards-Kortum R
    Methods Mol Biol; 2015; 1256():421-34. PubMed ID: 25626555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
    Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
    Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Premalignant Lesions of Uterine Cervix in A ResourceConstraint Setting: A Narrative Review.
    Grema BA; Aliyu I; Michael GC; Mafala MB
    West Afr J Med; 2019; 36(1):48-53. PubMed ID: 30924116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in colposcopy: new technologies to challenge current practice.
    Leeson S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():140-5. PubMed ID: 25282538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening in low resource settings using visual inspection with acetic acid.
    Carr KC; Sellors JW
    J Midwifery Womens Health; 2004; 49(4):329-37. PubMed ID: 15236713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HPV TEST SCREENING FOR THE DETECTION OF PRECANCEROUS CERVICAL LESIONS AND CERVICAL CANCER].
    Schejter E; Segal J
    Harefuah; 2018 Nov; 157(11):704-706. PubMed ID: 30457233
    [No Abstract]   [Full Text] [Related]  

  • 9. High-resolution microendoscopy: a point-of-care diagnostic for cervical dysplasia in low-resource settings.
    Grant BD; Fregnani JH; Possati Resende JC; Scapulatempo-Neto C; Matsushita GM; Mauad EC; Quang T; Stoler MH; Castle PE; Schmeler KM; Richards-Kortum RR
    Eur J Cancer Prev; 2017 Jan; 26(1):63-70. PubMed ID: 26637074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening and prevention in low-resource settings.
    Bradford L; Goodman A
    Clin Obstet Gynecol; 2013 Mar; 56(1):76-87. PubMed ID: 23337844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cervical precancers: a global perspective.
    Echelman D; Feldman S
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibilities of TruScreen for primary cervical cancer screening: a self-controlled study.
    Long S; Lei W; Feng Y; Lv D; Cai Y; Yang P
    Arch Gynecol Obstet; 2013 Jul; 288(1):113-8. PubMed ID: 23296464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
    Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in Teresina, PiauĂ­, Brazil: evaluation study using data of the Cervical Cancer Information System, 2006-2013.
    Damacena AM; Luz LL; Mattos IE
    Epidemiol Serv Saude; 2017; 26(1):71-80. PubMed ID: 28226009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2013 Dec; 122(6):1338-67. PubMed ID: 24264713
    [No Abstract]   [Full Text] [Related]  

  • 18. The current position and the future perspectives of cervical cancer screening.
    Bosgraaf RP; Siebers AG; De Hullu JA; Massuger LF; Bulten J; Bekkers RL; Melchers WJ
    Expert Rev Anticancer Ther; 2014 Jan; 14(1):75-92. PubMed ID: 24308681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing cervical cancer globally by acting locally: if not now, when?
    Gage JC; Castle PE
    J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
    [No Abstract]   [Full Text] [Related]  

  • 20. [New guidelines in regard to cervical cancer screening].
    Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
    Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.